Published in Am J Nephrol on January 23, 2009
Living donor practices in the United States. Adv Chronic Kidney Dis (2012) 0.96
Incidental kidney stones: a single center experience with kidney donor selection. Clin Transplant (2011) 0.82
The living kidney donor evaluation: focus on renal issues. Clin J Am Soc Nephrol (2012) 0.78
Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival. Int J Organ Transplant Med (2015) 0.76
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
A study of sexuality and health among older adults in the United States. N Engl J Med (2007) 9.66
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol (2004) 5.06
Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest (2003) 4.04
Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol (2005) 3.88
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet (2009) 3.65
Kidney stone disease. J Clin Invest (2005) 3.45
Clinical practice. Calcium kidney stones. N Engl J Med (2010) 3.24
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol (2010) 3.03
The use and interpretation of competing risks regression models. Clin Cancer Res (2012) 3.01
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int (2005) 2.51
The Social Connectedness of Older Adults: A National Profile* Am Sociol Rev (2008) 2.45
Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int (2004) 2.31
Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken) (2007) 2.27
Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int (2003) 2.17
Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol (2007) 2.15
Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int (2003) 2.15
Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken) (2015) 2.13
Should all living donors be treated equally? Transplantation (2002) 2.08
The Lung Image Database Consortium (LIDC): an evaluation of radiologist variability in the identification of lung nodules on CT scans. Acad Radiol (2007) 2.06
A systematic review of the quality of randomized controlled trials in head and neck oncology surgery. Laryngoscope (2014) 2.01
Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int (2005) 2.00
Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis. Cancer Biol Ther (2006) 1.92
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol (2002) 1.91
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res (2005) 1.90
Pregnancy in recipients of solid organs--effects on mother and child. N Engl J Med (2006) 1.84
Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in FSa fibrosarcomas. Int J Radiat Oncol Biol Phys (2008) 1.84
Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol (2007) 1.81
A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int (2008) 1.72
Nephrolithiasis. Prim Care (2008) 1.71
Social Networks in the NSHAP Study: rationale, measurement, and preliminary findings. J Gerontol B Psychol Sci Soc Sci (2009) 1.65
Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients. Clin Cancer Res (2012) 1.63
Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol (2010) 1.54
Endoscopic evidence of calculus attachment to Randall's plaque. J Urol (2006) 1.53
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52
Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int (2012) 1.52
Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol (2013) 1.51
Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int (2008) 1.50
The role of Randall's plaques in the pathogenesis of calcium stones. J Urol (2007) 1.46
Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int (2009) 1.45
New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol (2008) 1.45
Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol (2005) 1.44
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2006) 1.44
Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation (2002) 1.43
A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res (2009) 1.43
Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res (2011) 1.40
Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) (2008) 1.38
Sexuality: measures of partnerships, practices, attitudes, and problems in the National Social Life, Health, and Aging Study. J Gerontol B Psychol Sci Soc Sci (2009) 1.37
Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int (2005) 1.37
Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol (2008) 1.35
Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant (2008) 1.35
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res (2013) 1.31
Renal function in patients with nephrolithiasis. J Urol (2006) 1.27
Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Med Phys (2004) 1.27
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis (2007) 1.26
Leflunomide for polyomavirus type BK nephropathy. N Engl J Med (2005) 1.25
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int (2002) 1.25
Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int (2003) 1.24
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer. J Clin Oncol (2008) 1.23
Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of "truth". Acad Radiol (2009) 1.23
Prevalence of hyperoxaluria after bariatric surgery. J Urol (2008) 1.22
Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Res (2005) 1.21
Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int (2010) 1.21
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis (2011) 1.20
Medication data collection and coding in a home-based survey of older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.20
Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf (2010) 1.19
Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol (2008) 1.18
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int (2008) 1.17
Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int (2003) 1.15
Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother (2013) 1.14
Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab (2006) 1.14
Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis (2005) 1.12
Insights on the pathology of kidney stone formation. Urol Res (2005) 1.11
Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int (2002) 1.11
Correlates of formal work disability in an urban university systemic lupus erythematosus practice. J Rheumatol (2008) 1.10
Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab (2004) 1.09
Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol (2010) 1.08
Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant (2003) 1.08
Variability in mesothelioma tumor response classification. AJR Am J Roentgenol (2006) 1.06
In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int (2009) 1.06
Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues. Clin Cancer Res (2009) 1.06
Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer. Eur J Cancer (2005) 1.05
Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans. Acad Radiol (2005) 1.04
Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken) (2014) 1.03
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biol Blood Marrow Transplant (2012) 1.01
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE. Proc Natl Acad Sci U S A (2006) 1.01
Pregnancy after kidney transplantation. Clin J Am Soc Nephrol (2008) 1.00
Autoimmunity in patients with resistance to thyroid hormone. J Clin Endocrinol Metab (2010) 1.00
African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res (2007) 1.00
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. Biol Blood Marrow Transplant (2009) 0.99
Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Hum Pathol (2012) 0.99
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2008) 0.98